Seeing Is Believing
Currently out of the existing stock ratings of Gobind Singh, 16 are a BUY (94.12%), 1 are a HOLD (5.88%).
Analyst Gobind Singh works at HC WAINWRIGHT with a stock forecast success ratio of 20% fulfilled within 41.17 days on average.
Gobind Singh’s has documented 33 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RPHM, Reneo Pharmaceuticals at 08-Sep-2023.
Analyst best performing recommendations are on EVLO (EVELO BIOSCIENCES).
The best stock recommendation documented was for PTGX (PROTAGONIST THERAPEUTICS) at 5/24/2021. The price target of $48 was fulfilled within 57 days with a profit of $12.69 (35.94%) receiving and performance score of 6.31.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
2
$1.95 (3900.00%)
80
9 months ago
1/2 (50%)
$-5.88 (-74.62%)
83
Buy
10
$9.96 (24900.00%)
10
1 years 1 months 9 days ago
2/2 (100%)
$4.82 (93.05%)
79
Buy
5
$4.96 (12400.00%)
1 years 1 months 10 days ago
1/1 (100%)
$-0.98 (-16.39%)
4
Buy
280
1 years 2 months 25 days ago
1/3 (33.33%)
$120.6 (75.66%)
6
Buy
50
$49.95 (99900.00%)
12
1 years 5 months 10 days ago
3/4 (75%)
$4.2 (9.17%)
100
What Year was the first public recommendation made by Gobind Singh?